首页|期刊导航|中医科学杂志（英文）|A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA

A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA

Zhiying Yu Wenjuan Xu Tong Li Jie Yang Jianghua He Weijiang Zhang Siyuan Li Yunpeng Qi Yihui Yin Ling Dong

中医科学杂志（英文）2025，Vol.12Issue(1)：56-70,15.

中医科学杂志（英文）2025，Vol.12Issue(1)：56-70,15.DOI:10.1016/j.jtcms.2024.11.008

A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA

Zhiying Yu ¹Wenjuan Xu ¹Tong Li ¹Jie Yang ²Jianghua He ¹Weijiang Zhang ¹Siyuan Li ¹Yunpeng Qi ¹Yihui Yin ¹Ling Dong¹

作者信息

1. School of Life Sciences,Beijing University of Chinese Medicine,Beijing 102488,China
2. School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 102488,China
折叠

摘要

关键词

Colon/Gegen Qinlian decoction/Gut microbiota/Mechanism research/Pharmacodynamic component screening/TCM-gut microbiota interaction/Ulcerative colitis

Key words

Colon/Gegen Qinlian decoction/Gut microbiota/Mechanism research/Pharmacodynamic component screening/TCM-gut microbiota interaction/Ulcerative colitis

引用本文复制引用

Zhiying Yu,Wenjuan Xu,Tong Li,Jie Yang,Jianghua He,Weijiang Zhang,Siyuan Li,Yunpeng Qi,Yihui Yin,Ling Dong..A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA[J].中医科学杂志（英文）,2025,12(1):56-70,15.

基金项目

This work was supported by Fundamental Research Funds for the Central Universities(2022-ZXFZJJ-028). （2022-ZXFZJJ-028）

中医科学杂志（英文）

ISSN：2095-7548

访问量0

下载量0

段落导航